Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/2002
11/20/2002CN1380393A A polypeptide-adenosine triphosphatesynthetase-10.89 and polynucleotide for coding this polypeptide
11/20/2002CN1379989A Glycooxidase and its application in baking process
11/20/2002CN1094516C Detergent compositions containing specific lipolytic enzymes
11/20/2002CA2410038A1 Gelling composition
11/19/2002US6484103 Crystal structure
11/19/2002US6483010 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules
11/19/2002US6483009 Antisense intron inhibition of starch branching enzyme expression
11/19/2002US6483008 Methods for producing plants with elevated oleic acid content
11/19/2002US6482935 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002US6482924 Leptospira vaccine antigens for the prevention of Leptospirosis
11/19/2002US6482795 Tumor suppressor designated TS10q23.3
11/19/2002US6482631 Polynucleotides encoding indole-3-gylcerol phosphate synthase from soybean
11/19/2002US6482630 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
11/19/2002US6482629 Isolated human zinc metalloproteases, nucleic acids molecules encoding said enzymes, and uses thereof
11/19/2002US6482628 Multiply-substituted protease variants
11/19/2002US6482626 Human DNase
11/19/2002US6482625 Cytosolic phospholipase A2-beta enzymes
11/19/2002US6482624 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002US6482623 Lipid kinase
11/19/2002US6482622 Amylolytic enzyme variants
11/19/2002US6482621 Compositions and methods for fumonisin detoxification
11/19/2002US6482620 39443, novel human gamma-butyrobetaine hydroxylase
11/19/2002US6482605 Protein tyrosine phosphatase PTP20 and related products and methods
11/19/2002US6482599 Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such
11/19/2002US6482594 Made by exposing nucleic acid candidate sequences having photoreactive groups to the target molecule, irradiating complexes formed to crosslink, and separating the crosslinked complexes and amplifying to give the ligands
11/19/2002CA2232709C Method for isolating xylanase gene sequences from soil dna, compositions useful in such method and compositions obtained thereby
11/19/2002CA2185423C Enzyme granulates
11/19/2002CA2108358C Gene expression in bacilli
11/19/2002CA2040793C Plasmids expressing patatin and adp-glucose-pyrophosphorylase sequences
11/19/2002CA1341400C Process for preparing proteins
11/16/2002CA2383556A1 High-efficiency assay for protein mannosyl transferases
11/15/2002WO2001088149A1 Polypeptides cleaving telomeric repeats
11/15/2002CA2410974A1 Polypeptides cleaving telomeric repeats
11/14/2002WO2002092769A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/14/2002WO2002090578A2 Methods and means of histone methylation
11/14/2002WO2002090575A1 An assay for detecting inhibitors of the enzyme mueloperokidase
11/14/2002WO2002090571A2 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
11/14/2002WO2002090570A2 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
11/14/2002WO2002090552A2 Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing
11/14/2002WO2002090551A2 Self-containing lactococcus strain
11/14/2002WO2002090549A2 Compositions and methods for the modulation of viral maturation
11/14/2002WO2002090543A2 Regulation of human phosphatidic acid phosphatase type 2c-like protein
11/14/2002WO2002090531A2 Peptidylarginine deiminase 6
11/14/2002WO2002090530A2 Kinases and phosphatases
11/14/2002WO2002090525A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/14/2002WO2002090524A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002WO2002090523A2 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid
11/14/2002WO2002090522A2 Use of phosphorothiolate polynucleotides in ligating nucleic acids
11/14/2002WO2002090521A2 Drug metabolizing enzymes
11/14/2002WO2002090517A2 Novel human kinases and polynucleotides encoding the same
11/14/2002WO2002090497A2 Transgenic high tryptophan plants
11/14/2002WO2002090495A2 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002WO2002090493A2 Δ4-desaturase genes and uses thereof
11/14/2002WO2002090492A2 Fungal chitinases, polynucleotide sequences encoding same, promoters of same, and uses thereof
11/14/2002WO2002090377A2 Peptides that bind to dna and inhibit dna replication, and methods of use
11/14/2002WO2002090300A2 Nucleic acids and proteins with thioredoxin reductase activity
11/14/2002WO2002089829A2 Polymorphism in the eosinophil cationic protein (ecp) used in the treatment of e.g. cancer
11/14/2002WO2002089742A2 Heparin/heparosan synthase and methods of making and using same
11/14/2002WO2002089739A2 Peptide deformylase activated prodrugs
11/14/2002WO2002089730A2 Compounds and methods for the modulation of cd154
11/14/2002WO2002089561A1 Tyra genes and uses thereof
11/14/2002WO2002074948A3 Animal tissue with carbohydrate antigens compatible for human transplantation
11/14/2002WO2002072577A3 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
11/14/2002WO2002070679A3 Peptide fragments, derived from human telomerase reverse transcriptase
11/14/2002WO2002062370A3 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
11/14/2002WO2002061081A9 A novel gene bn01 mapping to chromosome 16q24.3
11/14/2002WO2002053713A3 Cloning of a human sulfotransferase
11/14/2002WO2002053704A3 Protein-protein interactions
11/14/2002WO2002048325A3 Regulation of human serine palmitoyltransferase
11/14/2002WO2002048323A3 Regulation of human uridine kinase
11/14/2002WO2002040635A3 HUMAN RNase H1 MUTANTS
11/14/2002WO2002036797A3 Process for the fermentative preparation of l-amino acids using strains of the enterobacteriaceae family
11/14/2002WO2002028906A3 Regulation of human sphingosine kinase-like protein
11/14/2002WO2002024878A3 Human e3 ubiquitin protein ligase-like enzyme
11/14/2002WO2002018623A3 Methods and reagents for protease inhibition
11/14/2002WO2002011530A9 Transgenic animal
11/14/2002WO2001040504A9 Methods and compositions for detecting nitroaromatic compounds
11/14/2002WO2001036659A3 Selectable cell surface marker genes
11/14/2002WO2001019842A9 Subunit optimized fusion proteins
11/14/2002US20020170095 Nucleotide sequences coding polypeptide for use in controlling plant propagation and gene expression
11/14/2002US20020170092 Modification of polysaccharides
11/14/2002US20020170091 Acyl CoA:cholesterol acyltransferase related nucleic acid sequences
11/14/2002US20020170090 Cell for use in the generation of prefrential plant enzymatic polypeptide
11/14/2002US20020170086 Fructan biosynthetic enzymes
11/14/2002US20020170083 Process for preparing an anti-oxidant
11/14/2002US20020170078 Calcineurin-related transgenic mammals, compositions and methods
11/14/2002US20020170077 Nucleotide sequences coding polypeptide for use in te diagnosis, prevention and treatment of atherosclerosis, ischemia/ reperfusion injuries, hypertension, restenosis and arterial inflammation
11/14/2002US20020169304 Nucleotide sequences coding polypeptide for use in the classification, diagnosis, prevention and treatment of downe's syndrome and alzheimers's diseases
11/14/2002US20020169303 Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods
11/14/2002US20020169294 Method of purifying calcium ion-binding protein
11/14/2002US20020169284 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system, virus, and visoin disorders
11/14/2002US20020169133 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
11/14/2002US20020168755 Mammalian TNF-alpha convertases
11/14/2002US20020168754 Nucleotide sequences coding polypeptides for use in the treatment of gastric, testicular, retinal, nervous system and immunological disorders
11/14/2002US20020168751 Nucleotide sequences coding polypeptides for use in the treatment of textiles, laundering detergent and in pulp and papermaking
11/14/2002US20020168750 Glucocerebrosidase for use in the treatment of bone disorders, gaucher's disease, thrombocytopenia and anemia
11/14/2002US20020168749 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer
11/14/2002US20020168748 Polypeptide for use in the diagnosis, prevention and treatment of fungal infections
11/14/2002US20020168747 Mammalian CDP-diacylglycerol synthase
11/14/2002US20020168746 Lipolytic enzymes